Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

AID binds to transcription-induced structures in c-MYC that map to regions associated with translocation and hypermutation

Abstract

Translocation and aberrant hypermutation of c-MYC are common in B-cell lymphomas. Activation-induced Cytidine Deaminase (AID) initiates switch recombination and somatic hypermutation in B cells by targeted deamination of transcribed genes. We show that transcription of the immunoglobulin S regions and c-MYC results in formation of similar DNA structures, ‘G-loops’, which contain a cotranscriptional RNA: DNA hybrid on the C-rich strand and single-stranded regions and G4 DNA on the G-rich strand. AID binds specifically to G-loops within transcribed S regions and c-MYC, and G-loops in c-MYC map to the regions associated with translocation breakpoints and aberrant hypermutation in B-cell lymphomas. Aberrant targeting of AID to DNA structures formed upon c-MYC transcription may therefore contribute to the genetic instability of c-MYC in B-cell malignancies.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Akasaka H, Akasaka T, Kurata M, Ueda C, Shimizu A, Uchiyama T and Ohno H . (2000). Cancer Res., 60, 2335–2341.

  • Apel TW, Mautner J, Polack A, Bornkamm GW and Eick D . (1992). Oncogene, 7, 1267–1271.

  • Avet-Loiseau H, Gerson F, Magrangeas F, Minvielle S, Harousseau JL and Bataille R . (2001). Blood, 98, 3082–3086.

  • Beale RC, Petersen-Mahrt SK, Watt IN, Harris RS, Rada C and Neuberger MS . (2004). J. Mol. Biol., 337, 585–596.

  • Bemark M and Neuberger MS . (2000). Oncogene, 19, 3404–3410.

  • Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL and Kuehl WM . (1996). Proc. Natl. Acad. Sci. USA, 93, 13931–13936.

  • Bergsagel PL and Kuehl WM . (2001). Oncogene, 20, 5611–5622.

  • Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R and Magrath I . (1993). Nat. Genet., 5, 56–61.

  • Boxer LM and Dang CV . (2001). Oncogene, 20, 5595–5610.

  • Bransteitter R, Pham P, Scharff MD and Goodman MF . (2003). Proc. Natl. Acad. Sci. USA, 100, 4102–4107.

  • Cesarman E, Dalla-Favera R, Bentley D and Groudine M . (1987). Science, 238, 1272–1275.

  • Chaudhuri J and Alt FW . (2004). Nat. Rev. Immunol., 4, 541–552.

  • Chaudhuri J, Tian M, Khuong C, Chua K, Pinaud E and Alt FW . (2003). Nature, 422, 726–730.

  • Chow LT and Broker TR . (1989). Methods Enzymol., 180, 239–261.

  • Cole MD . (1986). Annu. Rev. Genet., 20, 361–384.

  • Conticello SG, Thomas CJ, Petersen-Mahrt SK and Neuberger MS . (2005). Mol. Biol. Evol., 22, 367–377.

  • Duquette ML, Handa P, Vincent JA, Taylor AF and Maizels N . (2004). Genes Dev., 18, 1618–1629.

  • Durandy A . (2003). Eur. J. Immunol., 33, 2069–2073.

  • Fenton JA, Vaandrager JW, Aarts WM, Bende RJ, Heering K, van Dijk M, Morgan G, van Noesel CJ, Schuuring E and Kluin PM . (2002). Blood, 99, 716–718.

  • Gaidano G, Pasqualucci L, Capello D, Berra E, Deambrogi C, Rossi D, Maria Larocca L, Gloghini A, Carbone A and Dalla-Favera R . (2003). Blood, 102, 1833–1841.

  • Gordon MS, Kanegai CM, Doerr JR and Wall R . (2003). Proc. Natl. Acad. Sci. USA, 100, 4126–4131.

  • Gordon MS, Kato RM, Lansigan F, Thompson AA, Wall R and Rawlings DJ . (2000). Proc. Natl. Acad. Sci. USA, 97, 5504–5509.

  • Greeve J, Philipsen A, Krause K, Klapper W, Heidorn K, Castle BE, Janda J, Marcu KB and Parwaresch R . (2003). Blood, 101, 3574–3580.

  • Hanakahi LA, Sun H and Maizels N . (1999). J. Biol. Chem., 274, 15908–15912.

  • Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T and Kishimoto T . (1986). Nature, 324, 73–76.

  • Krumm A, Meulia T, Brunvand M and Groudine M . (1992). Genes Dev., 6, 2201–2213.

  • Kuppers R and Dalla-Favera R . (2001). Oncogene, 20, 5580–5594.

  • Larson ED, Duquette ML, Cummings WJ, Streiff RJ and Maizels N . (2005). Curr. Biol., 15, 470–474.

  • Levens DL . (2003). Genes Dev., 17, 1071–1077.

  • Maizels N and Scharff MD . (2004). Molecular Biology of B Cells, Honjo T, Neuberger M and Alt FW (eds). Elsevier Academic Press: Amsterdam, pp 327–338.

    Book  Google Scholar 

  • Michel B, Grompone G, Flores MJ and Bidnenko V . (2004). Proc. Natl. Acad. Sci. USA, 101, 12783–12788.

  • Migliazza A, Martinotti S, Chen W, Fusco C, Ye BH, Knowles DM, Offit K, Chaganti RS and Dalla-Favera R . (1995). Proc. Natl. Acad. Sci. USA, 92, 12520–12524.

  • Mills KD, Ferguson DO and Alt FW . (2003). Immunol. Rev., 194, 77–95.

  • Montesinos-Rongen M, Van Roost D, Schaller C, Wiestler OD and Deckert M . (2004). Blood, 103, 1869–1875.

  • Muller JR, Janz S and Potter M . (1995). Cancer Res., 55, 5012–5018.

  • Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y and Honjo T . (2000). Cell, 102, 553–563.

  • Muschen M, Re D, Brauninger A, Wolf J, Hansmann ML, Diehl V, Kuppers R and Rajewsky K . (2000a). Cancer Res., 60, 5640–5643.

  • Muschen M, Re D, Jungnickel B, Diehl V, Rajewsky K and Kuppers R . (2000b). J. Exp. Med., 192, 1833–1840.

  • Muto T, Muramatsu M, Taniwaki M, Kinoshita K and Honjo T . (2000). Genomics, 68, 85–88.

  • Neri A, Barriga F, Knowles DM, Magrath IT and Dalla-Favera R . (1988). Proc. Natl. Acad. Sci. USA, 85, 2748–2752.

  • Neuberger MS, Harris RS, Di Noia J and Petersen-Mahrt SK . (2003). Trends Biochem. Sci., 28, 305–312.

  • Pasqualucci L, Guglielmino R, Houldsworth J, Mohr J, Aoufouchi S, Polakiewicz R, Chaganti RSK and Dalla-Favera R . (2004). Blood, 104, 3318–3325.

  • Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, Baldini L, Chaganti RS, Klein U, Kuppers R, Rajewsky K and Dalla-Favera R . (1998). Proc. Natl. Acad. Sci. USA, 95, 11816–11821.

  • Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R and Dalla-Favera R . (2001). Nature, 412, 341–346.

  • Pham P, Bransteitter R, Petruska J and Goodman MF . (2003). Nature, 424, 103–107.

  • Potter M . (2003). Immunol. Rev., 194, 177–195.

  • Potter M and Wiener F . (1992). Carcinogenesis, 13, 1681–1697.

  • Preudhomme C, Roumier C, Hildebrand MP, Dallery-Prudhomme E, Lantoine D, Lai JL, Daudignon A, Adenis C, Bauters F, Fenaux P, Kerckaert JP and Galiegue-Zouitina S . (2000). Oncogene, 19, 2023–2032.

  • Rabbitts TH, Hamlyn PH and Baer R . (1983). Nature, 306, 760–765.

  • Raffeld M, Yano T, Hoang AT, Lewis B, Clark HM, Otsuki T and Dang CV . (1995). Curr. Top. Microbiol. Immunol., 194, 265–272.

  • Ramiro AR, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, Muramatsu M, Honjo T, Nussenzweig A and Nussenzweig MC . (2004). Cell, 118, 431–438.

  • Ramiro AR, Jankovic M and Nussenzweig MC . (2005). Nat. Immunol., 6, 117 ; author reply 118.

  • Ramiro AR, Stavropoulos P, Jankovic M and Nussenzweig MC . (2003). Nat. Immunol., 4, 452–456.

  • Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A and Durandy A . (2000). Cell, 102, 565–575.

  • Roix JJ, McQueen PG, Munson PJ, Parada LA and Misteli T . (2003). Nat. Genet., 34, 287–291.

  • Senthilkumar K, Grozema FC, Guerra CF, Bickelhaupt FM and Siebbeles LD . (2003). J. Am. Chem. Soc., 125, 13658–13659.

  • Shen HM, Peters A, Baron B, Zhu X and Storb U . (1998). Science, 280, 1750–1752.

  • Shou Y, Martelli ML, Gabrea A, Qi Y, Brents LA, Roschke A, Dewald G, Kirsch IR, Bergsagel PL and Kuehl WM . (2000). Proc. Natl. Acad. Sci. USA, 97, 228–233.

  • Smeland EB, Blomhoff HK, Ohlsson R, De Lange Davies C, Funderud S and Boye E . (1988). Eur. J. Immunol., 18, 1847–1850.

  • Suematsu S, Matsusaka T, Matsuda T, Ohno S, Miyazaki J, Yamamura K, Hirano T and Kishimoto T . (1992). Proc. Natl. Acad. Sci. USA, 89, 232–235.

  • Unniraman S, Zhou S and Schatz DG . (2004). Nat. Immunol., 5, 1117–1123.

Download references

Acknowledgements

We thank Molly Weiner for mapping G-loops within transcribed c-MYC, and Anton Krumm (Department of Radiation Oncology, University of Washington Medical Center) for providing the plasmid carrying the human c-MYC gene and Bobbie Schneider and staff for help with the electron microscopy. This research was supported by NIH R01 GM39799 and R01 GM65988 to NM, and R37 GM21422 and R01 ES13192 to MFG.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nancy Maizels.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duquette, M., Pham, P., Goodman, M. et al. AID binds to transcription-induced structures in c-MYC that map to regions associated with translocation and hypermutation. Oncogene 24, 5791–5798 (2005). https://doi.org/10.1038/sj.onc.1208746

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208746

Keywords

This article is cited by

Search

Quick links